EP2205318
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.10.2008EP published:
19.11.2014EP application number:
08841724.1
EPO information:
European Patent Register
Max expiry date:
21.10.2028
Title:
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR
Timeline
Today
22.10.2008EP application
19.11.2014EP Publication
Owner
Name:
Roche Glycart AGAddress:
Wagistrasse 18, 8952, Schlieren-Zuerich, CH
Inventor
Name:
FERTIG, GeorgAddress:
Penzberg, DE
Name:
FRIESS, ThomasAddress:
Diesen-Dettenhofen, DE
Name:
KLEIN, ChristianAddress:
Bonstetten, CH
Name:
UMANA, PabloAddress:
Wollerau, CH
Priority
Number:
07020820Date:
24.10.2007Country:
EP
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00, A61K 31/00